- ScreenPro Security (SCRN) has announced a non-brokered private placement financing for gross proceeds of up to $1,000,000
- The company will issue up to 20 million units for $0.05 per unit
- The gross proceeds will be used for general working capital
- The offering is expected to close on or about November 17, 2022
- ScreenPro is a medical technology company
- ScreenPro (SCRN) opened trading at C$0.025
ScreenPro Security (SCRN) has announced a non-brokered private placement financing for gross proceeds of up to $1,000,000.
The company will issue up to 20 million units for $0.05 per unit. Each unit will consist of one common share and one share purchase warrant. Each warrant will entitle the holder to acquire one additional share for a period of eighteen months.
The gross proceeds will be used for general working capital, growth, expansion, and general corporate purposes.
ScreenPro may pay a cash finders’ fee.
The offering is expected to close on or about November 17, 2022.
All securities issued will be subject to a statutory four-month hold period.
ScreenPro is a medical technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro also recently introduced Naturevan Nutrition Ltd. to its portfolio, providing vitamins and supplements that are made in Canada and distributed for sale online.
ScreenPro (SCRN) opened trading at C$0.025.